AXON Jan 2026 250.000 call
- Zacks
Is Most-Watched Stock Axon Enterprise, Inc (AXON) Worth Betting on Now?
Zacks.com users have recently been watching Axon (AXON) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- GlobeNewswire
Oncocyte Appoints Andrea James as Chief Financial Officer
IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to welcome Andrea as we approach the inflection point of commercial launch,” Oncocyte CEO Josh Riggs said. “She has a proven track record of guiding financial strategy through multiple phases of growth, raising and stewarding capital, and bu
- Zacks
Wall Street Bulls Look Optimistic About Axon (AXON): Should You Buy?
Based on the average brokerage recommendation (ABR), Axon (AXON) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
